Literature DB >> 7160433

Central and peripheral prazosin binding: an in vitro autoradiographic study in the rat.

M R Dashwood.   

Abstract

Using an in vitro autoradiographic technique the binding of [3H]prazosin to brain, spinal cord, heart and vascular tissue was studied. Histologically prepared tissue sections were incubated in 5 nM [3H]prazosin or 5 nM [3H]prazosin in the presence of 100 microM unlabelled prazosin base in order to establish sites exhibiting specific prazosin binding. Dense prazosin binding sites were found in all arterial tissue examined except mesenteric artery. Dense prazosin binding was also found in cardiac tissue. Prazosin binding to veins was present sometimes but often absent. Prazosin does not readily pass the blood brain barrier and in this in vitro study the only area, within the central nervous system, showing specific prazosin binding sites was the olfactory bulb. The selective binding of prazosin, an alpha 1-adrenoceptor antagonist, to arterial and cardiac tissue would suggest that the antihypertension induced by prazosin is mediated by a peripheral action.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160433     DOI: 10.1016/0014-2999(82)90395-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Regional brain distribution and tissue ontogenic expression of a family of alpha-adrenergic receptor mRNAs in the rat.

Authors:  S K McCune; M M Voigt
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

2.  An autoradiographic study of alpha 1-adrenergic receptors in the brain of the Japanese quail (Coturnix coturnix japonica).

Authors:  J Balthazart; G F Ball; B S McEwen
Journal:  Cell Tissue Res       Date:  1989-12       Impact factor: 5.249

3.  Effects of chronic prazosin, an alpha-1 adrenergic antagonist, on anxiety-like behavior and cortisol levels in a chronic unpredictable stress model in zebrafish (Danio rerio).

Authors:  Michael P O'Daniel; Maureen L Petrunich-Rutherford
Journal:  PeerJ       Date:  2020-01-31       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.